| XLS |
|
|
|
|
|
|
€ million |
Note |
2013 |
2012 |
|
Profit after tax |
|
1,209.1 |
579.0 |
|
Items of other comprehensive income that will not be reclassified to profit or loss in subsequent periods: |
|
|
|
|
Remeasurement of the net defined benefit liability |
|
|
|
|
Changes in remeasurement |
[49] |
98.8 |
–304.3 |
|
Deferred taxes |
[32] |
–16.3 |
37.2 |
|
Changes recognized in equity |
|
82.5 |
–267.1 |
|
|
|
82.5 |
–267.1 |
|
Items of other comprehensive income that may be reclassified to profit or loss in subsequent periods: |
|
|
|
|
Available-for-sale financial assets |
|
|
|
|
Fair value adjustments |
|
1.8 |
0.4 |
|
Reclassification to profit or loss |
|
–1.6 |
– |
|
Deferred taxes |
[32] |
–0.4 |
– |
|
Changes recognized in equity |
|
–0.2 |
0.4 |
|
Derivative financial instruments |
|
|
|
|
Fair value adjustments |
|
125.5 |
3.6 |
|
Reclassification to profit or loss |
|
–26.5 |
78.4 |
|
Reclassification to assets |
|
– |
– |
|
Deferred taxes |
[32] |
–25.3 |
–16.9 |
|
Changes recognized in equity |
|
73.7 |
65.1 |
|
Exchange differences on translating foreign operations |
|
|
|
|
Changes taken directly to equity |
|
–204.9 |
–34.6 |
|
Reclassification to profit or loss |
|
–8.9 |
– |
|
Changes recognized in equity |
|
–213.8 |
–34.6 |
|
|
|
–140.3 |
30.9 |
|
Other comprehensive income |
|
–57.8 |
–236.2 |
|
Comprehensive income |
|
1,151.3 |
342.8 |
|
of which attributable to Merck KGaA shareholders |
|
1,154.6 |
333.7 |
|
of which attributable to non-controlling interests |
[33] |
–3.3 |
9.1 |